Kendalee Olmo
Founder · CMO
Pipeline-to-Market Commercialization
InvenioNexTbrings science to market
Senior commercial launch expertise for emerging biotech.
Our experts bring backgrounds from
One partner.
Every phase.
Senior practitioners own every phase: pre-launch strategy, CLA governance, field execution, and post-launch KPI monitoring.
Launch Lifecycle
Pre-launch
Strategy, readiness, access
Launch execution
Sales, KOL, brand, digital
Post-launch
Insights, analytics, KPI monitoring
CLA governance
Cross-functional alignment
Field execution
Commercial operating rhythm
Performance
Commercial KPIs
Built for the
first-time launch reality.
0:1
First-time launches now outnumber established launchers
0%
FDA submissions now from first-time launchers
0%
First-timers exceeding expectations without expert support
80-0%
Long-term performance determined in first six months
Complete integrated capabilitiesAcross the full
Across the full
launch lifecycle.
Commercialization strategy from pipeline through U.S. market entry, launch readiness, execution, and post-launch KPI monitoring.
Pipeline-to-Market Commercialization
Pre-launch
U.S. & Global Launch Readiness
Pre-launch
Market Access Strategy
Pre-launch
Operations & Launch Excellence
Pre-launch
Sales Operations & Execution
Launch execution
KOL Liaison & Engagement
Launch execution
Brand Education & Patient Advocacy
Launch execution
Digital Solutions & AI Strategy
Launch execution
Insights & Analytics
Post-launch
Pipeline-to-Market Commercialization
Pre-launch
U.S. & Global Launch Readiness
Pre-launch
Market Access Strategy
Pre-launch
Operations & Launch Excellence
Pre-launch
Sales Operations & Execution
Launch execution
KOL Liaison & Engagement
Launch execution
Brand Education & Patient Advocacy
Launch execution
Digital Solutions & AI Strategy
Launch execution
Insights & Analytics
Post-launch
Insights & Analytics
Post-launch
Digital Solutions & AI Strategy
Launch execution
Brand Education & Patient Advocacy
Launch execution
KOL Liaison & Engagement
Launch execution
Sales Operations & Execution
Launch execution
Operations & Launch Excellence
Pre-launch
Market Access Strategy
Pre-launch
U.S. & Global Launch Readiness
Pre-launch
Pipeline-to-Market Commercialization
Pre-launch
Insights & Analytics
Post-launch
Digital Solutions & AI Strategy
Launch execution
Brand Education & Patient Advocacy
Launch execution
KOL Liaison & Engagement
Launch execution
Sales Operations & Execution
Launch execution
Operations & Launch Excellence
Pre-launch
Market Access Strategy
Pre-launch
U.S. & Global Launch Readiness
Pre-launch
Pipeline-to-Market Commercialization
Pre-launch
First-time launchers
need a different advisory model.
01
First-time launchers are now the majority
First-time launches now outnumber established launchers 2:1, changing the support model emerging biopharma companies need.
02
40% of FDA submissions come from first-timers
A growing share of submissions now comes from companies building commercial engines for the first time.
03
Only 20-30% exceed expectations without expert support
First-time launchers need senior operators who understand launch readiness, execution, and post-launch performance.
04
Accountable to commercial KPIs
InvenioNexT stays through strategy, GTM, and post-launch performance rather than exiting at a readiness report.
Execution beyond the readiness plan
Most advisory firms exit at the readiness plan, use junior associate delivery, or carry overhead built for Big Pharma budgets. We stay, and remain accountable through launch.
StrategyGTMPost-launchCLA governanceCommercial KPIs
End-to-end partner
Strategy through GTM and post-launch performance, not a readiness-plan handoff.
Senior launch experts only
Every engagement, every phase, led by practitioners who have held the roles they advise.
Right-sized for emerging biotech
Built for first-time launchers rather than Big Pharma overhead.
Commercial KPI accountability
A model tied to outcomes and post-launch performance monitoring.
Built by senior bio leaders who have personally held the commercial roles and led launches.
Emily Harris
Operations & Launch Excellence
Cross-Functional Launch Governance
Ray Short
Client Relations · Digital Engagement
Digital Strategy · AI Solutions
Let's start
the conversation
We'll follow up to discuss readiness, commercial execution, and post-launch performance.